Clinical Trials
31 trialsPredicting the Efficacy in Advanced Gastric Cancer.
City of Hope Medical Center
Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer
City of Hope Medical Center
HRCC1
Azienda Policlinico Umberto I
Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer
Hellenic Cooperative Oncology Group
EROS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CIN
Swami Rama Himalayan University
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
University of Wisconsin, Madison
Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
Tianjin Medical University Cancer Institute and Hospital
BiOnHER
Institut Català d'Oncologia
PROTECT-06
Institut de cancérologie Strasbourg Europe
COMET
UNICANCER
Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy
Qianfoshan Hospital
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
Moscow Clinical Scientific Center
Antineoplastic Drugs in Elderly Patients
Shandong University
Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary
Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery
Fox Chase Cancer Center
Immunotherapy in Lung Cancer: Treatment After IO Cessation.
European Lung Cancer Working Party
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
Alliance for Clinical Trials in Oncology
Real-world Data (RWD) of Ramucirumab Plus Paclitaxel
Hallym University Medical Center
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer
Harbin Medical University
Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
University of Michigan Rogel Cancer Center
Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
Hoosier Cancer Research Network
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
Duke University
LABC
Barretos Cancer Hospital
Chemotherapeutic Agents in Brain/Breast
Case Comprehensive Cancer Center
ANGIOMET
Spanish Lung Cancer Group
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
Roswell Park Cancer Institute